Zdrowie i gospodarka · 05/09/2023

FDA Announces Draft Guidance for Post-Warning Letter Meetings Under GDUFA

The FDA has released a draft guidance outlining the process for drug manufacturing facilities to request and participate in Post-Warning Letter Meetings, a program aimed at improving compliance with CGMP regulations.